Recommendations on the currently valid prevention of intravascular catheter-related infections from the Commission for Hospital Hygiene and Infection Prevention at the Robert Koch-Institute (KRINKO) are now 14 years old and therefore out-dated.
‘Every single hour, more than 200,000 people worldwide are being diagnosed or treated with our devices,’ Michael Reitermann, COO of Siemens Healthineers, proudly reports. No reason, however, for Siemens to rest on its laurels. Quite the contrary: the company continues to drive innovation.
Genetics stepping ahead as Spain-based researchers develop biomedical robots that can help in the study of rare diseases, neurodegenerative disorders and cancer, as well as the creation of orphan drugs.
Abionic SA announced the receipt of CE Mark (Conformité Européenne) for two novel tests using its easy to use testing platform, abioSCOPE. The CE Mark allows Abionic to commercialize its tests for sepsis risk assessment and management (PSP Test) and iron deficiency throughout the European Union.
Up to ten years ago only a handful of antibodies that could be detected in the blood were known to neurology.
Researchers at Cincinnati Children’s Hospital Medical Center grew functional stomach and intestinal tissues to study diseases and new drugs. They use pluripotent stem cells to generate human stomach tissues in a petri dish that produce acid and digestive enzymes.
Researchers at University of Vienna discover unexpected role of signalling protein in hepatocellular carcinoma.
Scientists at Washington University School of Medicine in St. Louis have detailed the structure of a molecule that has been implicated in Alzheimer’s disease. Knowing the shape of the molecule — and how that shape may be disrupted by certain genetic mutations — can help in understanding how Alzheimer’s and other neurodegenerative diseases develop and how to prevent and treat them.
Neural stem cells have been found in epileptic brain tissue - outside the regions of the brain where they normally reside. In a group of patients who underwent surgery for epilepsy, over half had stem cells where healthy individuals do not have them, according to a study from Sahlgrenska Academy.
Pathology does not appear to have much in common with satellites, but the concept that satellites combine spatial resolution and image quality will be the future of disease diagnosis, according to researchers.
A new molecular diagnostics system is revolutionising analysis of hospital samples across an area of northern Italy. The Greater Romagna Area Hub Laboratory has recently installed the Beckman Coulter DxN VERIS Molecular Diagnostics System and is already reporting improved workflow and quicker turnaround time for results.
Magnets instead of antibiotics could provide a possible new treatment method for blood infection. This involves the blood of patients being mixed with magnetic iron particles, which bind the bacteria to them after which they are removed from the blood using magnets. The initial laboratory tests at Empa in St. Gallen have been successful, and seem promising.
Helping to save time and increase comfort at the microscope, Olympus’ new DP74 camera delivers intelligent imaging with a range of innovative features designed to facilitate the workflow and enhance return on investment (ROI).
Experts at the European Committee on Antimicrobial Susceptibility Testing (EUCAST), who define the optimal drug concentrations to inhibit the growth of pathogens, have found that genetic methods cannot yet be used to test for susceptibility in a number of important bacterial species.
The ability to digitise results from patient samples has been one of the key enabling technologies that make personalised medicine possible now, says Dr Fiona Carragher, the Deputy Chief Scientific Officer for NHS England.
Beckman Coulter Life Sciences is launching an international HIV/AIDS award at the 2016 conference for the African Society for Laboratory Medicine (ASLM) being held in Cape Town, South Africa (December 3 to 8).
In the largest study of its kind, UT Southwestern Medical Center researchers and colleagues in Europe identified a gene variant that suppresses the desire to drink alcohol.
Visiopharm A/S announces its acquisition of LRI Imaging AB. With more than 10 years of experience in the field, many successful installations in routine diagnostic pathology labs, LRI Imaging AB is the leading diagnostic digital pathology provider in Sweden.
Tecan is making it quicker and easier than ever before for manufacturers to develop instruments for advanced liquid handling applications. The launch of the new Cavro Omni Flex further extends the flexibility and convenience of the company’s popular Cavro Omni Robot by offering more hardware options to complement its precision pipetting, including frames, worktables, power and input/output…
The RX altona shines a new light on semi-automated clinical chemistry testing with increased auto-functionality and ground-breaking technology. Revolutionising the RX series with its bold look, innovative design, and outstanding performance, it sets the benchmark for the next generation of the RX series clinical chemistry analysers.
The Elix High-Throughput water purification system is designed to provide laboratories with a reliable water purification solution for daily water volumes of up to 9000 liters. At the heart of a central water purification solution, the Elix High-Throughput system offers full connectivity, providing authorized users real-time remote monitoring via computer, tablet or smartphone with access to all…
After nearly two decades of unsuccessful attempts, researchers from the University of Chicago Medicine and the Cincinnati Children’s Hospital Medical Center have created the first mouse model for the most common form of infant leukemia. Their discovery could hasten development and testing of new drug therapies.
Menarini-Silicon Biosystems announced the company’s DEPArray single-cell isolation technology played a key role in a study conducted by researchers from The University of Manchester to develop a model for predicting whether small-cell lung cancer patients will be sensitive or resistant to initial chemotherapy treatment.
BBI Solutions has launched Morffi, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassaysThe technology, developed in-house by BBI Solutions scientists, improves the limit of detection of an assay, providing an increase in sensitivity of up to ten times and a faster time to result.
Pathology services in the UK are struggling to cope with the increasing number of patient samples that need to be tested, according to a Cancer Research UK report* published today.